Table 1.
Baseline Characteristics of Patients With Nonacute AIH, A‐AIH, and AS‐AIH
| Nonacute AIH Group (n = 50) | A‐AIH Group (n = 17) | AS‐AIH Group (n = 14) | P Value* | |
|---|---|---|---|---|
| Sex, female | 37 (74) | 12 (71) | 11 (79) | 0.88 |
| Age, years | 56 (14‐77) † | 49 (13‐71) | 48 (11‐64) | 0.07 |
| Cirrhosis | 18 (36) | 5 (29) | 8 (57) | 0.25 |
| HAI | — | 11.5 (1‐18) ‡ | 12 (1‐18) § | 0.91 |
| Biochemical variables | ||||
| IgG, g/l | 21.7 (8.2‐72) | 25.1 (11.4‐49.4) | 27.5 (19‐43) | 0.019 |
| Total bilirubin, µmol/L | 17 (5‐47) | 112 (51‐595) | 179 (49‐563) | <0.001 |
| AST, U/L | 205 (30‐1630) | 1286 (100‐2527) | 1029 (103‐2582) | <0.001 |
| ALT, U/L | 226 (35‐1602) | 1275 (38‐3400) | 1130 (66‐2703) | <0.001 |
| Alkaline phosphatase, U/L | 154 (48‐603) | 200 (85‐410) | 246 (125‐588) | 0.12 |
| GGT, U/L | 191 (27‐1122) | 145 (36‐1317) | 109 (33‐1098) | 0.26 |
| Albumin, g/L | 41 (25‐50) | 35 (15‐44) | 29 (22‐45) | <0.001 |
| INR | 1.1 (0.9‐1.3) | 1.2 (1.0‐1.5) | 1.6 (1.5‐2.8) | <0.001 |
| Platelets, ×109/L | 190 (53‐487) | 179 (55‐297) | 174 (38‐420) | 0.53 |
| MELD score | 7 (6‐17) | 16 (11‐22) | 21 (16‐27) | <0.001 |
Data are given as n (%) or median (range).
*
Mann‐Whitney U test was used to determine significance for continuous variables, and chi‐square test was used for categorical variables.
†
All values are median (range) unless otherwise specified.
‡
n = 10.
§
n = 9.